Teva MS Drug Patents Invalidated By Fed. Circ.
The Federal Circuit ruled Friday that several patents covering Teva Pharmaceuticals USA Inc.'s multiple sclerosis drug Copaxone are invalid, reversing a lower court and clearing the way for Mylan Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article